LinkSPINE receives FDA clearance for FacetLINK: 4 key points

LinkSPINE’s FacetLINK has received FDA (510)k clearance.

Advertisement

Here are four key points on the new device:

 

1. FacetLINK incorporated two screws and a plated cross-connector assembly to stabilize the spine following a tissue-sparing midline or microsurgical decompression.

 

2. The plate assemblies are available in numerous sizes as well as an expandable version.

 

3. It has been approved for a number of indications, such as pseudoarthrosis and failed previous fusion; spondylolisthesis; and degenerative disc disease.

 

4. LinkSPINE is a company focused developing simple and less invasive implants and techniques for spinal surgery.

 

More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics’ 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.